The antineutrophil cytoplasmic antibodies (ANCA typical or not) in current medical practice

被引:4
|
作者
Renaudineau, Y. [3 ]
Beauvillard, D. [3 ]
Segalen, I. [2 ,3 ]
Leroyer, C. [1 ]
Le Meur, Y. [2 ]
Youinou, P. [1 ]
机构
[1] CHU Brest, Hop Cavale Blanche, Serv Pneumol, F-29609 Brest, France
[2] CHU Brest, Hop Cavale Blanche, Serv Nephrol, F-29609 Brest, France
[3] CHU Brest, Hop Morvan, Immunol Lab, F-29609 Brest, France
来源
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE | 2011年 / 26卷 / 01期
关键词
Antineutrophil cytoplasmic antibodies (ANCA); Vasculitis; Proteinase; 3; Myeloperoxidase (MPO); INTERNATIONAL CONSENSUS STATEMENT; WEGENERS-GRANULOMATOSIS; NECROTIZING GLOMERULONEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; SYSTEMIC VASCULITIS; DISEASE-ACTIVITY; AUTOANTIBODIES; PROTEINASE-3; NEUTROPHILS; MYELOPEROXIDASE;
D O I
10.1016/j.immbio.2010.12.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Antineutrophil cytoplasmic antibodies (ANCA) are important serological markers mostly for the small vessel systemic vasculitides. Numerous reports have established an interest for the combination of the indirect immunofluorescence (IFI) and the ELISA anti-PR3 and anti-MPO in such indication. However, conflicting results may exist between IFI and ELISA that require additional assays and such special measures are important to help and avoid clinical misinterpretation. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
  • [41] Frequency of Antineutrophil cytoplasmic antibodies (ANCA) in active coccidioidomycosis infection.
    Chan, H
    Carroll, P
    Naguwa, S
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4100 - 4100
  • [42] SCREENING FOR ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) - IS INDIRECT IMMUNOFLUORESCENCE THE METHOD OF CHOICE
    BASLUND, B
    SEGELMARK, M
    WIIK, A
    SZPIRT, W
    PETERSEN, J
    WIESLANDER, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 99 (03): : 486 - 492
  • [43] ANTINUCLEAR AND ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN THE SERA OF PATIENTS WITH FELTYS SYNDROME
    JUBY, A
    JOHNSTON, C
    DAVIS, P
    RUSSELL, AS
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 (03): : 185 - 188
  • [44] WHEN AND WHY CHECK FOR ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN DERMATOLOGY - RESPONSE
    HUMBERT, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1995, 122 (08): : 559 - 559
  • [45] Absence of antineutrophil cytoplasmic antibodies (ANCA) in allergic bronchopulmonary aspergillosis (ABPA).
    Greenberger, PA
    Kanwar, Y
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S197 - S197
  • [46] Antineutrophil cytoplasmic antibodies (ANCA) - a 'red flag' in patients with systemic sclerosis
    Casari, S.
    Haeney, M.
    Farrand, S.
    Herrick, A. L.
    RHEUMATOLOGY, 2001, 40 : 118 - 118
  • [47] Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA)
    Wang, GC
    Csernok, E
    de Groot, K
    Gross, WL
    JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 208 (02) : 203 - 211
  • [48] THE PRESENCE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    de Freitas, Diana Azeredo
    Streets de Abreu Zaiden, Ana Luiza Menezes
    Veloso, Paula Alencar
    da Silva, Nilzio Antonio
    Rego, Jozelia
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S50 - S50
  • [49] Antineutrophil cytoplasmic antibodies (ANCA) and renal disease in Malaysian patients with SLE
    Loh, TS
    Looi, LM
    Kamaliah, S
    Tan, SY
    Trevisin, M
    Savige, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 472A - 472A
  • [50] International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)
    Savige, J
    Gillis, D
    Benson, E
    Davies, D
    Esnault, V
    Falk, RJ
    Hagen, EC
    Jayne, D
    Jennette, JC
    Paspaliaris, B
    Pollock, W
    Pusey, C
    Savage, COS
    Silvestrini, R
    van der Woude, F
    Wieslander, J
    Wiik, A
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 111 (04) : 507 - 513